99955-7 |
Country |
Loc |
^Entity |
Pt |
Nom |
|
|
ACTIVE |
Entity Country |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
99955-7 |
|
|
|
|
Observation |
|
|
|
0 |
Entity Country |
|
|
|
N |
|
ADMIN; Location; Nominal; Point in time; Random |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99956-5 |
Complete address |
Addr |
^Entity |
Pt |
Nom |
|
|
ACTIVE |
Entity Complete address |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
99956-5 |
|
|
|
|
Observation |
|
|
|
0 |
Entity Complete address |
|
|
|
N |
|
Address; ADMIN; Nominal; Point in time; Random |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99957-3 |
Address type |
Type |
^Entity |
Pt |
Nom |
|
|
ACTIVE |
Entity Address type |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
99957-3 |
|
|
|
|
Observation |
|
|
|
0 |
Entity Addr type |
|
|
|
N |
|
Addr type; ADMIN; Nominal; Point in time; Random; Typ |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99958-1 |
Address use |
Type |
^Entity |
Pt |
Nom |
|
|
ACTIVE |
Entity Address use |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN |
|
99958-1 |
|
|
|
|
Observation |
|
|
|
0 |
Entity Address use |
|
|
|
N |
|
ADMIN; Nominal; Point in time; Random; Typ |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99959-9 |
Urothelial carcinoma gene expression score |
Score |
Urine |
Pt |
Qn |
Molgen |
|
ACTIVE |
Urothelial carcinoma gene expression score in Urine by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
MOLPATH |
|
99959-9 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
UC gene expression score Ur |
|
|
|
N |
|
Bladder cancer; Molecular genetics; Molecular pathology; MOLPATH; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; UA; UC gene expression score; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
9996-0 |
R wave amplitude.lead V6 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
R wave amplitude in lead V6 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9996-0 |
|
EKG |
|
|
Observation |
|
|
|
0 |
R wave Amp L-V6 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; R prime; R' wave Amp L-V6; R wave Amp L-V6; Random; Right; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
99960-7 |
ADAMTS13 gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
ADAMTS13 gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99960-7 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
ADAMTS13 Full Mut Anl Bld/T Seq |
|
|
|
N |
|
Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99961-5 |
Myeloproliferative neoplasm multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Myeloproliferative neoplasm multigene analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99961-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
MPN multigene analysis Bld/T |
|
|
|
N |
|
Acute myeloid leukemia; Blood; Chronic Myeloid Leukemias; Document; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; MPN multigene analysis; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99962-3 |
JAK2 gene exon 12 full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
JAK2 gene exon 12 full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99962-3 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
JAK2 exon 12 Full Mut Anl Bld/T Seq |
|
|
|
N |
|
Blood; Document; Erythrocytosis; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; JAK2 exon 12; Janus kinase 2; Janus kinase 2 gene; JTK10; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Polycythemia vera; PV; Random; sequencing of entire coding region; THCYT3; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99963-1 |
JAK2 gene exon 14 full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
JAK2 gene exon 14 full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99963-1 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
JAK2 exon 14 Full Mut Anl Bld/T Seq |
|
|
|
N |
|
Blood; Document; Erythrocytosis; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; JAK2 exon 14; Janus kinase 2; Janus kinase 2 gene; JTK10; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Polycythemia vera; PV; Random; sequencing of entire coding region; THCYT3; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99964-9 |
MPL gene exon 10 full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
MPL gene exon 10 full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99964-9 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
MPL exon 10 Full Mut Anl Bld/T Seq |
|
|
|
N |
|
Blood; CD110; C-MPL; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; MPL exon 10; MPL proto-oncogene, thrombopoietin receptor; MPLV; Mut; Mutations; MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; THCYT2; thrombopoietin receptor mutations; Tissue; Tissue, unspecified; TPOR; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99965-6 |
ASXL1 gene exon 13 full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
ASXL1 gene exon 13 full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99965-6 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
ASXL1 exon 13 Full Mut Anl Bld/T Seq |
|
|
|
N |
|
additional sex combs like 1, transcriptional regulator; ASXL1 exon 13; Blood; BOPS; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99966-4 |
KIT gene exon 17 full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
KIT gene exon 17 full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99966-4 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
KIT Exon 17 Full Mut Anl Bld/T Seq |
|
|
|
N |
|
Blood; CD117; c-KIT; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; KIT Exon 17; mast/stem cell growth factor receptor; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; PBT; piebald trait; Point in time; Proto-oncogene tyrosine-protein kinase Kit; Random; SCFR; sequencing of entire coding region; soluble KIT variant; Tissue; Tissue, unspecified; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99967-2 |
Atypical hemolytic uremic syndrome multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Atypical hemolytic uremic syndrome multigene analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99967-2 |
|
Molgen |
|
|
Both |
|
|
|
0 |
aHUS multigene analysis Bld/T |
|
|
|
N |
|
aHUS multigene analysis; Atyp; Blood; Document; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Reactive; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99968-0 |
Thrombotic microangiopathy multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Thrombotic microangiopathy multigene analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99968-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
TMA multigene analysis Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; TMA multigene analysis; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99969-8 |
PLG gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
PLG gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99969-8 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
PLG Full Mut Anl Bld/T Seq |
|
|
|
N |
|
Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Plasminogen; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9997-8 |
R wave axis |
Angle |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
R wave axis |
|
MIN |
DefinitionDescription |
|
|
deg |
|
|
|
|
|
|
EKG.MEAS |
|
9997-8 |
|
EKG |
|
|
Observation |
|
|
|
0 |
R wave axis |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right |
2.48 |
1.0i |
|
|
|
|
|
|
|
deg |
|
|
|
0 |
99970-6 |
Hereditary thrombocytopenia multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Hereditary thrombocytopenia multigene analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99970-6 |
|
Molgen |
|
|
Both |
|
|
|
0 |
IT multigene analysis Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Gene; Gene panel; IT multigene analysis; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99971-4 |
Hemophagocytic lymphohistiocytosis multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Hemophagocytic lymphohistiocytosis multigene analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99971-4 |
|
Molgen |
|
|
Both |
|
|
|
0 |
HLH multigene analysis Bld/T |
|
|
|
N |
|
Blood; Document; Finding; Findings; Gene; Gene panel; HLH multigene analysis; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99972-2 |
Hearing loss multigene analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
Hearing loss multigene analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
99972-2 |
|
Molgen |
|
|
Both |
|
|
|
0 |
Hearing loss multigene analy Bld/T |
|
|
|
N |
|
Blood; Deafness multi-Gene study; Document; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; Otogenetics Deafness Panel; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99974-8 |
No injury due to a thermal source |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
No risk of injury due to a thermal source |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
99974-8 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey; SURVEY.PNDS; Ulcer |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99975-5 |
No injury related to a chemical source |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
No injury related to a chemical source |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
99975-5 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey; SURVEY.PNDS; Ulcer |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99976-3 |
No injury related to a radiation source |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
No injury related to a radiation source |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
99976-3 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey; SURVEY.PNDS; Ulcer |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99977-1 |
No injury related to transfer &or transport during care |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
No injury related to transfer AndOr transport during care |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
99977-1 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS; Ulcer |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
99978-9 |
No harm related to medications administered |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
No harm related to medications administered |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.PNDS |
|
99978-9 |
|
|
|
|
Observation |
|
|
|
0 |
|
|
|
|
N |
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |